Your missing my point
CSL moving into gene therapy tells you the core business is under threat.
I suggest you study the frequency of dose of CSL HAE v Takeda/Shire and the efficacy.
Then come back and tell me what do patient prefer.
CSL is ridiculously expensive.
its the most expensive Pharma company in the world !!!
The CSL pattern, page-266
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$296.00 |
Change
-0.690(0.23%) |
Mkt cap ! $143.3B | |||
| Open | High | Low | Value | Volume |
| $296.70 | $297.28 | $295.09 | $108.7M | 367.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 929 | $295.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $296.44 | 474 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |